NCT04997473 Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
| NCT ID | NCT04997473 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Los Angeles |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2021-08-15 |
| Primary Completion | 2027-01-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2021-08-15 with a primary completion date of 2027-01-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pilot study enrolling obese post HSCT (hematopoietic stem cell transplantation) patients at the hematology/oncology clinic at the Mattel Children's Hospital, University of California, Los Angeles. Parameters include percent over the 95th percentile (%BMIp95), zBMI, fasting metabolic metrics, addictive eating habits, and motivation for change.
Eligibility Criteria
Inclusion Criteria: * Patients ≥ 13 and ≤ 30 years old with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study. * Both male and female patients will be eligible. * Patients must classify as obese, represented as Body mass index \[BMI\] ≥85th percentile for age and gender. * Patients must also be able to read English since the app intervention is only available in English form. Exclusion Criteria: * Patients who are ≤ 13 or ≥ 30 years old are not eligible for the study. * Patients who are \< 100 days post-transplant at initial consultation will not be eligible for the study, but may become eligible if they are \>100 days post-transplant at their next consultation that falls within the enrollment window. * Patients whose BMI does not fall under the obese category will be excluded. * No patients will be excluded for any specific underlying medical condition, but decisions will be made on a case by case basis if a patient's functioning is deemed to significantly interfere with intervention participation.
Contact & Investigator
Theodore B Moore, MD
PRINCIPAL INVESTIGATOR
UCLA Health
Frequently Asked Questions
Who can join the NCT04997473 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 30 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04997473 currently recruiting?
Yes, NCT04997473 is actively recruiting participants. Contact the research team at belenramirez@mednet.ucla.edu for enrollment information.
Where is the NCT04997473 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT04997473 clinical trial?
NCT04997473 is sponsored by University of California, Los Angeles. The principal investigator is Theodore B Moore, MD at UCLA Health. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.